Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

December 31, 2015

Conditions
Ischemic Stroke
Interventions
DEVICE

intravascular stent therapy

Device selection depended on arterial access and lesion morphology. For patients with smooth arterial access and Mori A lesion or the mid-basilar artery and distal M1 segment lesions, the Apollo balloon-mounted stent was selected. For patients with tortuous arterial access and Mori B or C lesion, or lesion with a significant mismatch in the diameter between proximal and distal segment, angioplasty plus self-expanding stent (Gateway balloon plus Wingspan stent system) is preferred . For patients with tortuous arterial access with a Mori A lesion, or small target vessel diameter (\<2.5 mm), direct dilation with Gateway balloon was selected. If severe dissection or elastic recoil occurred after angioplasty, a balloon-mounted stent (for patients with less tortuous access) or Wingspan (for patients with severe tortuous access or small target vessel) stent were allowed to be implanted.

Trial Locations (1)

100050

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Zhongrong Miao

OTHER

NCT01968122 - Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China | Biotech Hunter | Biotech Hunter